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Abstract
Introduction: Epidemiological studies on all types of illicit drug use among ath-
letes are essential for both the sport community and drug control achievements.
Here, we investigated the prevalence and associated factors of amphetamine
use in body builders in Tehran, Iran, 2007. 
Material and methods: This study is a secondary analysis of a substance use
survey done in 103 randomly selected gymnasia in Tehran (capital city of Iran).
The survey was conducted from November 2007 to January 2008 and included
843 randomly selected bodybuilders (aged 40 years or less). By interviews via
questionnaires the following data were obtained: age, job, marital status, edu-
cation level, housing status, average monthly family income, number of family
members, gymnasium area (m2), number of trainers, number of gymnasium
members, initiation time (months), weekly duration of the sporting activity (h),
monthly cost of the sporting activity, purpose of participating in sporting activ-
ity, and history of anabolic steroid and amphetamine use.
Results: One hundred twenty (13.3%) body builders reported a history of amphet-
amine use. According to the results of regression analysis, being married (risk
ratio – RR = 0.540), and participating in body building to enhance self-esteem
(RR = 0.423) or to enhance sport performance (RR = 0.545) had protective effects
on amphetamine use. However, having university qualifications (RR = 1.843),
using anabolic steroids (RR = 1.803) and participating in sport to maintain fit-
ness (RR = 2.472) were linked to increased risk of amphetamine use. 
Conclusions: Well-educated bodybuilders were more likely to use amphetamines,
and why this is so needs to be discovered. If further studies show that they are
not aware of the dangers associated with amphetamine use, providing them
with information should be considered.
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Introduction
The sport-drug relationship has always fascinated the scientific com-
munity, and there has been a plethora of research into the patterns of drug
abuse in athletes [1]. Participating in sports is believed to be protective
against drug abuse [2, 3]. Nevertheless, the prevalence of drug abuse among
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athletes of different disciplines has prompted many
researchers over the years to probe into the whys
and the wherefores of this phenomenon [4, 5]. There
seems to be a general consensus among the
researchers that in the sport-drug relationship, the
kind of drug and different characteristics of a sport-
ing activity are the key factors [1, 6, 7].
There is a new trend of psychoactive drug use
by athletes [8]. Even with strict regulations of dop-
ing [9] illicit drugs are used by athletes to help them
to enhance performance [10, 11]. According to one
epidemiological investigation, the likelihood of
amphetamine use might be higher among people
who are engaged in any type of sporting activities,
either the competitive or non-competitive forms
[12]. Amphetamines do not lessen fatigue but can
mask it, and that is what renders them pernicious
to the health of athletes [5, 10]. Those involved in
sports that require intense anaerobic activities are
more likely to gravitate toward amphetamines
because they are believed to prolong anaerobic
metabolism [13]. 
There is little information about amphetamine
use in the general population in Iran [14]. The main
reason is that it is a relatively new phenomenon in
this country [15]. Most studies in the field of drug
abuse are focused on opiates, including opium, opi-
um derivates such as juice and residue, and hero-
in [16-18], and some studies do not even report
amphetamine abuse [19]. In 2007, amphetamines
were the dominant drugs in 4% of Iranian drug
users [20]. However, considering the huge number
of drug dependents in Iran (1.2-1.8 million) [21, 22],
the total number would be considerable and is esti-
mated to be between 48,000 and 72,000. One sur-
vey in 15-25 year old participants in Tehran report-
ed the prevalence of 18.5% for ecstasy abuse, with
a higher prevalence in males, lower education lev-
el, higher family income and users of other drugs
at the same time [23]. There are published reports
on amphetamines in different Iranian sub-popula-
tions [24]. The highest reported prevalence is 18%
for methamphetamine use among people with
high-risk sexual behavior [23].
Here, we investigated the prevalence and asso-
ciated factors of amphetamine use among a ran-
dom sample of body builders in Tehran, Iran, in
2007.
Material and methods
Design and setting
This is a secondary analysis of a substance
abuse survey carried out from November 2007 to
January 2008, in Tehran, Iran. The study was fund-
ed by the Research Center for Substance Abuse and
Dependence and done under the financial support
of the Iranian National Drug Control Headquarters.
Samples and sampling
One hundred and three gymnasia were select-
ed using simple (one level) random sampling
(computer-generated random numbers). From
these clubs, we invited all (n = 930) bodybuilders
who were present at the club at the time of sam-
pling. Inclusion criteria were male gender and 
age of 16 to 40 years. From all who were invited,
843 agreed to participate in our study (response
rate = 90.6%).
Codes of ethics
Verbal consent was obtained from the athletes
and they were reassured that the data would be
kept strictly confidential. All participants were giv-
en information about the purpose of the study. Par-
ticipants' names were not recorded to assure con-
fidentiality (anonymous study). We have conducted
this study according to the 'Ethical Principles for
Medical Research involving Human Subjects' of the
Helsinki Declaration and it is approved by the ethics
committee of the Research Center for Substance
Abuse and Dependence and the Ministry of Health
of the Islamic Republic of Iran.
Process
Data on participants’ social and demographic
characteristics, sporting activity patterns and sub-
stance abuse history were collected via an inter-
view which took about 45 min for each participant,
using structured questionnaires. 
Independent variables
Independent variables included the following
variables: age, job, marital status, education level,
housing status, average monthly family income,
number of family members, gymnasium area (m2),
number of trainers, number of gymnasium mem-
bers, initiation time (months), weekly duration of
the sporting activity (h), monthly cost of the sport-
ing activity, purpose of participating in the sport-
ing activity, and history of anabolic steroid use. The
purpose of participating in the sporting activity was
defined by the answer to the following six phrases
(yes/no): 1) to gain a higher social level, 2) to attract
further attention, 3) to enhance one’s self-esteem,
4) to enhance one’s sports performance, 5) to have
a healthy life, and 6) to maintain one’s fitness.
Main outcome
The dependent variable was amphetamine use
(self-reported data). It was assessed by using the
following question: "Until now, have you ever tried
any type of amphetamines such as crystal meth,
glass, MDMA, lover’s speed, the love drug, ecstasy,
crystal, speed, XTC, E, or X?" Similar items had been
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used by previous researchers on lifetime drug use
of adolescents in Iran.
Statistical analysis
For this survey, a sample size of 900 was deter-
mined considering a confidence interval of 2%, for
an estimated prevalence of 18% for methamphet-
amine use (according to the only existing epidemi-
ological report in Iran [23] and a total number of
7,000, based on the estimate of the Iran Power Lift-
ing Federation).
The data were analyzed using the SPSS statisti-
cal package program. To compare non-normally dis-
tributed variables, the Mann-Whitney U test was
used and the information is given as median and
inter-quartile range (IQR). All independent variables
were entered into a multiple logistic regression
model to determine the associated factors of
amphetamine use in body builders (forward selec-
tion method) and the results are reported as rela-
tive risks (RR) and 95% confidence intervals 
(95% CI). The missing values in the analysis were
relatively few. A p value less than 0.05 was consid-
ered significant. 
Results
Participants
From a total of 843 participants with mean age
of 25.2 (standard deviation – SD = 5.9) years (min-
imum of 16 and maximum of 40), 112 (13.3%) body
builders reported a history of amphetamine use (in
the form of methamphetamine hydrochloride
(meth) or 3,4-methylenedioxy-N-methylamphe  -
tamine (MDMA)). We had 106 MDMA users, one
meth user, and 6 users of both. Up to the com-
mencement time of the study, the participants had
worked out an average of 20 months (IQR = 42) at
an average of 6 h (IQR = 3) per week in gymnasia.
They had on average monthly family income of
$631.5 (IQR = $631.5) and the sport clubs had on
average 2 trainers (IQR = 1) and 160 members 
(IQR = 80).
Amphetamine users versus non-users
The amphetamine users and non-users were not
significantly different in age, job, monthly family
income, marital status, or housing status. Howev-
er, the proportion of the users who had university
qualifications was higher than non-users (42.7% vs.
27.7%, p = 0.001). Additionally, the rate of concur-
rent use of anabolic steroids was not significantly
different in amphetamine users and non-users
(19.6% vs. 17.1%; p = 0.509) (Table I). 
The different characteristics of the gymnasia (i.e.
area and number of trainers and members) and the
sporting activity patterns (i.e. initiation time and
weekly activity duration) were not significantly dif-
ferent between the two groups. Regarding the pur-
pose of body building, the users reported the pur-
suit of fitness (46.4% vs. 23.4%, p < 0.001) or
a healthy life (64.3% vs. 44.7%, p < 0.001) more
than did the non-users, while the latter cited
enhancing self-esteem more than the former 
(p < 0.001) (Table I).
Associated factors of amphetamine use in body
builders
The results of our regression analysis demon-
strated that being married (RR = 0.540, 95% CI =
0.312-0.935, p = 0.028), participating in sporting
activity to enhance self-esteem (RR = 0.423, 
95% CI = 0.268-0.665, p < 0.001) or to enhance
sports performance (RR = 0.545, 95% CI = 0.303-
0.980, p = 0.043) were protective factors in body
builders for abusing amphetamines. On the other
hand, having university qualifications (RR = 1.843,
95% CI = 1.182-2.873, p = 0.007), using anabolic
steroids (RR = 1.803, 95% CI = 1.029-3.160, p = 0.039)
and participating in sporting activity to maintain
fitness (RR = 2.472, 95% CI = 1.587-3.851, p < 0.001)
were strong risk factors for abuse of amphetamines
in body builders.
Discussion
According to this study, one in eight body
builders in Tehran reported amphetamine use.
Among the body builders, being married and par-
ticipating in body building to enhance self-esteem
or to enhance sport performance were associated
with a lower likelihood of amphetamine use. How-
ever, having university qualifications, using anabolic
steroids and participating in sporting activity to
maintain fitness were associated with a higher like-
lihood of amphetamine use in body builders.
In the present study, 13% of the body builders
admitted to amphetamine use (mostly ecstasy).
A previous study in Iran indicated a rise in amphet-
amine use (especially ecstasy) among the young
generation [25], the same as a United Nations’
report [26] and other regional investigations [27,
28]. Despite worldwide concern, it is impossible to
estimate accurately the actual prevalence of
amphetamine use in the general population,
because this substance is used mostly by the young
population in recreational places and ceremonies
[29] and only a few users are likely to refer for treat-
ment or to judiciary centers [30]. In addition, strict
anti-doping regulations and screenings [9] lead to
relative success in discouraging athletes from
amphetamine use in competitions. Therefore, stud-
ies in this group at competitive levels are liable to
underestimate the facts about the use of this par-
ticular substance by sportspersons.
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The higher likelihood of amphetamine use
among those with a higher educational degree may
be related to the lack of knowledge about the dan-
gers of amphetamines in well-educated body-
builders. The literature also shows a high rate of
drug use among highly educated people [31]. In Iran,
a link between poor knowledge about ampheta-
mines and ecstasy has been reported previously
[23, 32, 33]. Therefore, providing accurate informa-
tion may be critically important to prevent amphet-
amine abuse. According to the literature, informing
about the hazards of drug use may decrease drug
use prevalence in communities [34].
In the present study, employment was not relat-
ed to amphetamine use, but being married and
having university qualifications were associated
with amphetamine use: the body builders who were
married used amphetamines less, while those who
had university qualifications had a higher likelihood
of amphetamine use. A literature review shows
some evidence for no link between socio-demo-
graphic characteristics and amphetamine use [35]
and no association between lower levels of educa-
tion and amphetamine use [30, 32]. Some studies
also show that individuals in stable relationships
may be at lower risk for illicit drug use [32]. The
higher rate of drug use among people with higher
educational level may be explained by the gap
between knowledge and behavior and the link
between impulsivity and illicit drug use [36]. It has
been shown that a proportion of people use illicit
drugs despite being aware of its consequences [37]. 
Similar to current findings, a link between the
history of anabolic steroid use and the likelihood of
psychotropic drug abuse has been reported [38-40].
Both amphetamines [32] and anabolic steroids tend
to be used concurrently with other substances [38].
This link may be explained by similar biological
mechanisms of substance use and dependency
[39]. This finding highlights the need for controlling
for another when one is reported.
As athletes use amphetamines not only for
recreation, but also for performance improvement
[11, 13], we expect a link between amphetamine use
Parameter History of amphetamine use Value of pa
Yes, N = 112 No, N = 731
Median (IQR) Median (IQR)
Age [years] 23 (7) 24 (9) 0.544
Number of family members 4 (2) 4 (2) 0.223
Monthly family income [$] 736.8 (842.2) 631.5 (631.5) 0.073
Gymnasium area [m2] 250 (200) 250 (140) 0.983 
Number of trainers 2 (1) 2 (1) 0.407
Number of members 150 (100) 160 (80) 0.084
Monthly membership cost [$] 13.2 (13.0) 12.6 (9.5) 0.715
Initiation time of sport [months]  24 (42) 20.5 (42) 0.833
Weekly duration of sport [h] 6 (4) 6 (4) 0.162
N (%) N (%) Value of pb
Being married 21 (18.8) 196 (26.9) 0.067
University qualifications 47 (42.7) 198 (27.7) 0.001*
Self-owned home 34 (30.4) 241 (33.3) 0.539
Being jobless 30 (26.8) 196 (26.8) 0.995
Using steroids 22 (19.6) 125 (17.1) 0.509
Doing sport to:
Gain a higher social level 15 (13.4) 207 (28.4) 0.001*
Attract further attention  13 (11.6) 117 (16.0) 0.228
Enhance one’s self-esteem 42 (37.5) 402 (55.1) 0.001*
Enhance one’s sports performance 18 (16.1) 176 (24.1) 0.060
Have a healthy life 72 (64.3) 326 (44.7) < 0.001*
Maintain one’s fitness 52 (46.4) 171 (23.4) < 0.001*
*value of p less than 0.05, aMann-Whitney U test, bχ2 test
Table I. Socio-demographic characteristics and sporting activity patterns in body builders with and without history
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and sport variables. Within sport related charac-
teristics in the present study, the only variable with
such a link was the motivation for body building.
Participation in body building to maintain fitness
was linked to higher likelihood of amphetamine
use, as opposed to those who sought better self-
esteem and sports performance. The literature indi-
cates a higher likelihood of illicit drug use among
athletes who participate in sports at competitive
levels [1, 4].
Body builders may use amphetamines for recre-
ation or for enhancement of sport performance, but
the present study did not assess these possible
motivations for amphetamine use. We also did not
ask about the level of knowledge about ampheta-
mines. This information could shed light on the pos-
sible preventive strategies to explain if drug edu-
cational programs can be helpful in this population;
but further studies are needed in this regard.
It is widely acknowledged that illicit drug use is
a difficult subject to study. We, too, encountered
a number of hurdles that limited the scope of the
present study. For instance, a considerable amount
of missing data on the details of the body builders’
amphetamine use precluded us from analyzing their
drug use patterns. The data were all self-reported,
and the cross-sectional design of the study ren-
dered us unable to define a causative relationship
between amphetamine use and the associated fac-
tors. However, as the athletes in the present study
were interviewed about amphetamine use in a set-
ting outside competitions and there was no fear of
doping regulations, the results of this study should
be relatively close to reality. We should add to the
above that body building is not an Olympic sport
and usually there is no doping control.
In this study we used interviews for data collec-
tion. The literature shows that self-reported illicit
drug use can be both reliable and valid in different
populations [41]. However, for further studies, we
suggest using self-administered questionnaires for
drug use surveys because they have been shown
to increase the rate of drug use as opposed to inter-
views [42]. 
In conclusion, the possible causes of the high-
er likelihood of amphetamine use among body-
builders with higher education warrants further
studies. If further studies confirm a lack of knowl-
edge of hazards associated with amphetamine
use, providing appropriate information should be
considered. We hope that the results of the pres-
ent study can serve as a baseline for future stud-
ies on amphetamine abuse and its associated risk
factors in athletes.
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